Wordt geladen...
Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
Early-stage NSCLC (stages I and II, and some IIIA diseases) accounts for approximately 30% of non-small cell lung cancer (NSCLC) cases, with surgery being its main treatment modality. The risk of disease recurrence and cancer-related death, however, remains high among NSCLC patients after complete s...
Bewaard in:
| Gepubliceerd in: | Vaccines (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310081/ https://ncbi.nlm.nih.gov/pubmed/34201650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070689 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|